Pharmarama attends The Inaugural Forum on Pre-Approval Expanded Access Programmes for the Bio/Pharmaceutical Industry
November 2009

Inaugural Forum on Pre-Approval Expanded Access Programmes for the Bio

In November 2009, CBI held the Inaugural Forum on Pre-Approval Expanded Access Programmes.  Designed to provide the bio/pharmaceutical industry with a better understanding of Expanded Access, Named Patient and Compassionate Use Programmes, the conference attracted more than 60 delegates.

Although educational and thought-provoking for many attendees, the program has been redesigned in 2010 to attract and appeal to a larger and more experienced delegation. 

One of the major changes to the program is the layout.  In 2010,CBI intend to break the agenda down based on the stages in a product’s lifecycle when expanded access typically occurs.  Starting with Pre-Registration, the agenda transitions to Early Registration and then to the End of a Product’s Life. 

Supported by in-depth case studies, this new format promises a logical, organized and comprehensive agenda.